377
Views
153
CrossRef citations to date
0
Altmetric
Theme: Migraine & headache - Review

Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications

, &
Pages 379-394 | Published online: 09 Jan 2014

References

  • FurmanJM, Jacob RG. A clinical taxonomy of dizziness and anxiety in the otoneurologic setting. J. Anxiety Disord.15, 9–26 (2001).
  • Jacob RG, Furman JM, Balaban CD. Psychiatric aspects of vestibular disorders. In: Handbook of Neurotology/Vestibular System. Baloh RW, Halmagyi GM (Eds). Oxford University Press, Oxford, UK, 509–528 (1996).
  • Staab JP. Chronic dizziness: the interface between psychiatry and neuro-otology. Curr. Opin. Neurol.19(1), 41–48 (2006).
  • Staab JP, Ruckenstein MJ. Chronic dizziness and anxiety: effect of course of illness on treatment outcome. Arch. Otolaryngol. Head Neck Surg.131(8), 675–679 (2005).
  • Staab JP, Ruckenstein MJ. Expanding the differential diagnosis of chronic dizziness. Arch. Otolaryngol. Head Neck Surg.133, 170–176 (2007).
  • Furman JM, Balaban CD, Jacob RG, Marcus DA. Migraine-anxiety associated dizziness (MARD): a new disorder? J. Neurol. Neurosurg. Psychiatry76, 1–8 (2005).
  • Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr. Opin. Neurology16, 5–13 (2003).
  • Marcus DA, Furman JM, Balaban CD. Motion sickness in migraine sufferers. Expert Opin. Pharmacotherapy6(15), 2691–2697 (2005).
  • Radat F, Swendsen J. Psychiatric morbidity in migraine: a review. Cephalagia25, 165–178 (2004).
  • Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache32, 300–304 (1992).
  • Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology56(4), 436–441 (2001).
  • Lempert T, Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine. J. Neurol.256, 333–338 (2009).
  • Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalagia22, 117–124 (2002).
  • Drummond PD. Triggers of motion sickness in migraine sufferers. Headache45(6), 653–656 (2005).
  • Drummond PD, Granston A. Facial pain increases nausea and headache during motion sickness in migraine sufferers. Brain127(3), 526–534 (2004).
  • Furman JM, Marcus DA. A pilot study of rizatriptan and visually-induced motion sickness in migraineurs. Int. J. Med. Sci.6, 212–217 (2009).
  • Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J. Headache Pain DOI: 10.1007/s10194-010-0250-z (2010) (Epub ahead of print).
  • Neuhauser HK. Epidemiology of vertigo. Curr. Opin. Neurology20, 40–46 (2007).
  • Eckhardt-Henn A, Tschan R, Best C, Dieterich M. [Somatoform vertigo syndrome]. Nervenarzt80, 909–917 (2009).
  • Staab JP. Psychological aspects of vestibular disorders. In: Vertigo and Imbalance: Clinical Neurophysiology of the Vestibular System. Eggers SDZ, Zee DS (Eds). Elsevier, MA, USA, 502–522 (2010).
  • Helzer JE, Kraemer HC, Krueger RF. The feasibility and need for dimensional psychiatric diagnoses. Psycholog. Med.36, 1671–1680 (2006).
  • Helzer JE, Kraemer HC, Krueger RF et al.Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-V . American Psychiatric Association, VA, USA (2008).
  • Jacob RG, Redfern MS, Furman JM. Space and motion discomfort and abnormal balance control in patients with anxiety disorders. J. Neurol. Neurosurg. Psychiatry80, 74–78 (2009).
  • Jacob RG, Woody S, Clark DB et al. Discomfort with space and motion: a possible marker of vestibular dysfunction assessed by the situational characteristics questionnaire. J. Psychopathol. Behav. Assess.15, 299–324 (1993).
  • Furman JM, Redfern MS, Jacob RG. Vestibulo-ocular function in anxiety disorders. J. Vestib. Res.16, 209–215 (2006).
  • Redfern MS, Furman JM, Jacob RG. Visually induced postural sway in anxiety disorders. J. Anxiety Disord.21, 704–716 (2007).
  • Dieterich M, Krafczyk S, Querner V, Brandt T. Somatoform phobic postural vertigo and psychogenic disorders of stance and gait. Adv. Neurol.87, 225–233 (2001).
  • Bronstein AM. Visual vertigo syndrome: clinical and posturographic findings. J. Neurol. Neurosurg. Psychiatry59, 472–476 (1995).
  • Ruckenstein MJ, Staab JP. Chronic subjective dizziness. Otolaryngol. Clin. N. Am.42, 71–77 (2009).
  • Eckhardt-Henn A, Best C, Bense S et al. Psychiatric comorbidity in different organic vertigo syndromes. J. Neurol.255, 420–428 (2008).
  • Balaban CD, Jacob RG. Background and history of the interface between anxiety and vertigo. J. Anxiety Disord.15, 27–51 (2001).
  • Balaban CD, Yates BJ. Vestibulo-autonomic interactions: a teleologic perspective. In: Springer Handbook of Auditory Research: The Vestibular System. Highstein SN, Fay RR, Popper AN (Eds). Springer-Verlag, NY, USA, 286–342 (2004).
  • Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol. Psychiatry54, 504–514 (2003).
  • Craig AD. How do you feel – now? The anterior insula and human awareness. Nat. Rev. Neurosci.10, 59–70 (2009).
  • Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci.3, 655–666 (2002).
  • Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: inplications for the selective antimigraine action of triptans. J. Neurosci.23, 10988–10997 (2003).
  • Mitchell JL, Silverman MB, Aicher SA. Rat trigeminal lamina I neurons that project to the thalamic or parabrachial nuclei contain the µ-opioid receptor. Neuroscience128, 571–582 (2004).
  • Caterina MJ, Leffler A, Malmberg AB et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science288, 306–313 (2000).
  • Caterina MJ, Leffler A, Schumacher MA et al. The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature389, 816–824 (1997).
  • Ichikawa H, Jin HW, Terayama R et al. Calretinin-containing neurons which co-express parvalbumin and calbindin D-28k in the rat spinal and cranial sensory ganglia; triple immunofluorescence study Brain Res.1061, 118–123 (2005).
  • Kevetter GA, Leonard RB. Molecular probes of the vestibular nerve II. Characterization of neurons in Scarpa’s ganglion to determine separate populations. Brain Res.928, 18–29 (2002).
  • Xiang Z, Bo X, Burnstock G. P2X receptor immunoreactivity in the rat cochlea, vestibular ganglion and cochlear nucleus. Hear. Res.128, 190–196 (1999).
  • Balaban CD, Zhou J, Li HS. Type 1 vanilloid receptor expression by mammalian inner ear ganglion cells. Hear. Res.175(1–2), 165–170 (2003)
  • Ahn SK, Balaban CD. Distribution of 5-HT1B and 5-HT1D receptors in the inner ear. Brain Res.1346, 92–101 (2010).
  • Kong WJ, Scholtz AW, Kammen-Jolly K et al. Ultrastructural evaluation of calcitonin gene-related peptide immunoreactivity in the human cochlea and vestibular endorgans. Eur. J. Neurosci.15, 487–497 (2002).
  • Popper P, Ishiyama A, Lopez I, Wackym PA. Calcitonin gene-related peptide and choline acetyltransferase colocalization in the human vestibular periphery. Audiol. Neurootol.7, 298–302 (2002).
  • Charney DS, Deutsch A. A functional neuroanatomy of anziety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit. Rev. Neurobiol.10, 419–446 (1996).
  • Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. J. Clin. Psychiatry58(Suppl. 2), 4–12 (1997).
  • Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry157, 493–505 (2000).
  • Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety12(Suppl. 1), 2–19 (2000).
  • Bernard JF, Bester H, Besson JM. Involvement of the spino–parabrachio–amygdaloid and –hypothalmic systems in the autonomic and emotional aspects of pain. In: The Emotional Motor System. Hostege G, Bandler R, Saper CB (Eds). Elsevier, Amsterdam, The Netherlands, 243–255 (1996).
  • Gauriau C, Bernard JF. Pain pathways and parabrachial circuits in the rat. Exp. Physiol.87(2), 251–258 (2002).
  • Balaban CD. Vestibular projections to the Edinger-Westphal and anteromedian nuclei of rabbits. Brain Res.963, 121–131 (2003).
  • Balaban CD. Vestibular nucleus projections to the parabrachial nucleus in rabbits: Implications for vestibular influences on autonomic function. Exp. Brain Res.108, 367–381 (1996).
  • Porter JD, Balaban CD. Connections between the vestibular nuclei and regions that mediate autonomic function in the rat. J. Vestib. Res.7, 63–76 (1997).
  • Balaban CD. Projections from the parabrachial nucleus to the vestibular nuclei: potential substrates for autonomic and limbic influences on vestibular responses. Brain Res.996, 126–137 (2004).
  • Moga MM, Herbert H, Hurley KM et al. Organization of cortical, basal forebrain, and hypothalamic afferents to the parabrachial nucleus in the rat. J. Comp. Neurol.295, 624–661 (1990).
  • Herbert H, Moga MM, Saper CB. Connections of the parabrachial nucleus with the nucleus of the solitary tract and medullary reticular formation in the rat. J. Comp. Neurol.293, 540–580 (1990).
  • Fulweiler CE, Saper C. Subnuclear organization of the efferent connections of the parabrachial nucleus in the rat. Brain Res. Rev.7, 229–259 (1984).
  • Krout KE, Loewy AD. Parabrachial nucleus projections to midline and intralaminar thalamic nuclei of the rat. J. Comp. Neurol.428, 475–494 (2000).
  • Lang W, Büttner-Ennever JA, Büttner U. Vestibular projections to the monkey thalamus: an autoradiographic study. Brain Res.177, 3–17 (1979).
  • Maciewicz R, Phipps BS, Bry J, Highstein SM. The vestibulothalamic pathway: contribution of the ascending tract of Deiters. Brain Res.252, 1–11 (1982).
  • Shiroyama T, Kayahara T, Yasui Y, Nomura J, Nakano K. The vestibular nuclei of the rat project to the lateral part of the thalamic parafascicular nucleus (centromedian nucleus in primates). Brain Res.704, 130–134 (1995).
  • Shiroyama T, Kayahara T, Yasui Y, Nomura J, Nakano K. Projections of the vestibular nuclei to the thalamus in the rat: a Phaseolus vulgaris leucoagglutinin study. J. Comparative Neurology407, 318–332 (1999).
  • Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain131, 2538–2552 (2008).
  • Dieterich M, Bense S, Lutz S et al. Dominance for vestibular cortical function in the non-dominant hemisphere. Cereb. Cortex13(9), 994–1007 (2003).
  • Bucher S, Dieterich M, Wiesmann M et al. Cerebral functional magnetic resonance imaging of vestibular, auditory, and nociceptive areas during galvanic stimulation. Ann. Neurol.44, 120–125 (1998).
  • Eikhoff SB, Weiss PH, Amunts K, Fink GR, Zilles K. Identifying human parieto-insular vestibular cortex using fMRI and cytoarchitectonic mapping. Hum. Brain Mapp.27, 611–621 (2006).
  • Fasold O, von Brevern M, Kuhberg M et al. Human vestibular cortex identified with caloric stimulation in functional magnetic resonance imaging. NeuroImage17, 1384–1392 (2002).
  • Lobel E, Kleine JF, Le Bihan D, Leroy-Willig A, Berthoz A. Functional MRI of galvanic vestibular stimulation. J. Neurophysiol.80, 2699–2709 (1998).
  • Suzuki M, Kitano H, Ito R et al. Cortical and subcortical vestibular response to caloric stimulation detected by functional magnetic resonance imaging. Cogn. Brain Res.12, 441–449 (2001).
  • Bottini G, Karnath HO, Vallar G et al. Cerebral representations for egocentric space: functional-anatomical evidence from caloric vestibular stimulation and neck vibration. Brain124, 1182–1196 (2001).
  • Karnath HO, Dieterich M. Spatial neglect – a vestibular disorder? Brain129, 293–305 (2006).
  • Russell N, Horii A, Smith PF, Darlington CL, Bilkey DK. Bilateral peripheral vestibular lesions produce long-term changes in spatial learning in the rat. J. Vestib. Res.13, 9–16 (2003).
  • Schautzer F, Hamilton D, Kalla R, Strupp M, Brandt T. Spatial memory deficits in patients with chronic bilateral vestibular failure. Ann. NY Acad. Sci.1004, 316–324 (2003).
  • Brandt T, Schautzer F, Hamilton D et al. Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans. Brain128, 2732–2741 (2005).
  • Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson R. Neuroanatomical correlates of happiness, sadness, and disgust. Am. J. Psychiat.154, 926–933 (2000).
  • Reiman EM, Lane RD, Ahern GL et al. Neuroanatomical correlates of externally and internally generated human emotion. Am. J. Psychiat.154, 918–925 (1997).
  • Shin LM, Dougherty DD, Orr SP et al. Activation of anterior paralimbic structures during guilt-related script-driven imagery. Biol. Psychiat.48, 43–50 (2000).
  • Craig AD. A new view of pain as a homeostatic emotion. Trends Neurosci.26(6), 303–307 (2003).
  • Wiens S. Interoception in emotional experience. Curr. Opin. Neurol.18, 442–447 (2005).
  • Schnitzler A, Ploner M. Neurophysiology and functional neuroanatomy of pain perception. J. Clin. Neurophysiol.17, 592–603 (2000).
  • Jacob RG, J.Furman MR, Clark DB, Durrant JD, Balaban CD. Psychogenic dizziness. In: The Vestibulo-Ocular Reflex and Vertigo. Sharpe JA, Barber HO (Eds). Raven Press, NY, USA, 305–317 (1993).
  • Hsieh JC, Hannerz J, Ingvar M. Right-lateralised central processing for pain of nitroglycerine-induced cluster headache. Pain67, 59–68 (1996).
  • Craig AD. Forebrain emotional asymmety: a neuroanatomical basis? Trends Cogn. Sci.9, 566–571 (2005).
  • Carmona JE, Holland AK, Harrison DW. Extending the functional cerebral systems theory of emotion to the vestibular modality: a systematic and integrative approach. Psychol. Bull.135, 286–302 (2009).
  • Baumgarten HG, Grozdanovic Z. Anatomy of central serotonergic projection systems. In: Serotonergic Neurons and 5-HT Receptors in the CNS. Baumgarten HG, Gothert M (Eds). Springer, Berlin, Germany, 41–89 (1997).
  • Jacobs BL, Azmitia E. Structure and function of the brain serotonin system. Physiol. Rev.72, 165–229 (1992).
  • Bagdy E, Kiraly I, Harsing LG Jr. Reciprocal innervation between serotonergic and GABAergic neurons in the raphe nuclei of the rat. Neurochem. Res.25, 1465–1473 (2000).
  • Stamp JA, Semba K. Extent of colocalization of serotonin and GABA in the neurons of the rat raphe nuclei. Brain Res.677, 39–49 (1995).
  • Stratford TR, Wirtshafter D. Ascending dopaminergic projections from the dorsal raphe nucleus in the rat. Brain Res.511, 173–176 (1990).
  • Yoshida M, Shiriuza M, Tanaka M, Semba K, Fibiger HC. Dopaminergic neurons in the nucleus raphe dorsalis innervate the prefrontal cortex in the rat: a combined retrograde tracing and immunohistochemical study using anti-dopamine serum. Brain Res.496, 373–376 (1989).
  • Clements JR, Madl JE, Johnson RL, Larson AA, Beitz AJ. Localization of glutamate, glutaminase, aspartate and aspartate aminotransferase in the rat. Exp. Brain Res.67, 594–602 (1987).
  • Lechner J, Leah JD, Zimmermann M. Brainstem peptidergic neurons projecting the the medial and lateral thalamus and zona incerta in the rat. Brain Res.603, 47–56 (1993).
  • Petit JM, Luppi PH, Peyron C, Rampon C, Jouvet M. VIP-like immunoreactive projections from the dorsal raphe and linear raphe nuclei to the bed nucleus of the stria terminalis demonstrated by a double immunohistochemical method in the rat. Neurosci. Lett.193, 77–80 (1995).
  • Halberstadt AL, Balaban CD. Organization of projections from the raphe nuclei to the vestibular nuclei in rats. Neuroscience120, 571–592 (2003).
  • Halberstadt AL, Balaban CD. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience140(3), 1067–1077 (2006).
  • Vertes R. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol.313, 643–668 (1991).
  • Vertes RP, Kocsis B. Projections of the dorsal raphe nucleus to the brain stem: PHA-L analysis in the rat. J. Comp. Neurol.340, 11–26 (1994).
  • Halberstadt AL, Balaban CD. Anterograde tracing of projections from the dorsal raphe nucleus to the vestibular nuclei. Neuroscience143, 641–654 (2006).
  • Halberstadt AL, Balaban CD. Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei. Neuroscience147, 207–223 (2007).
  • Balaban CD. Neural substrates linking balance control and anxiety. Physiol. Behav.77, 469–475 (2002).
  • Ahn SK, Balaban CD. Regional distribution of 5-HT1A, 1B, and 1D receptors in rat vestibular nuclei (VN). Soc. Neurosci. Abstracts37, 180.5 (2007).
  • Ahn SK, Khalmuratova R, Jeon SY et al. Colocalization of 5-HT1F receptor and glutamate in neurons of the vestibular nuclei in rats. NeuroReport20, 111–115 (2009).
  • Afridi SK, Giffin NJ, Kaube H et al. A positron emission tomography study in spontaneous migraine. Arch. Neurol.62, 1270–1275 (2005).
  • Afridi SK, Goadsby PJ. Neuroimaging of migraine. Curr. Pain Headache Rep.10, 221–224 (2006).
  • May A. A review of diagnostic and functional imaging in headache. J. Headache Pain7, 174–184 (2006).
  • May A, Matharu M. New insights into migraine: application of functional and structural imaging. Curr. Opin. Neurol.20, 306–309 (2007).
  • Michelsen K, Schmitz C, Steinbusch HW. The dorsal raphe nucleus – from silver stainings to a role in depression. Brain Res. Rev.55, 329–342 (2007).
  • Schuerger RJ, Balaban CD. Immunohistochemical demonstration of regionally-selective projections from locus coeruleus to the vestibular nuclei in rats. Exp. Brain Res.92, 351–359 (1993).
  • Schuerger RJ, Balaban CD. Organization of the coeruleo-vestibular pathway in rats, rabbits and monkeys. Brain Res. Rev.30, 189–217 (1999).
  • Loughlin SE, Foote SL, Bloom FE. Efferent projections of locus coeruleus: topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience18, 291–306 (1986).
  • Moore RY, Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci.2, 113–168 (1979).
  • Gorman JM, Liebowitz MR, Fyer AJ, Stein J. A neuroanatomical hypothesis for panic disorder. Am. J. Psychiatry146, 148–161 (1989).
  • Ninan PT. The functional anatomy, neurochemistry and pharmacology of anxiety. J. Clin. Psychiatry60(Suppl. 22), 12–17 (1999).
  • Pratt JA. The neuroanatomical basis of anxiety. Pharmacol. Ther.55, 149–181 (1992).
  • Aston-Jones G, Cohen JD. Adaptive gain and the role of the locus coeruleus–norepinephrine system in optimal performance. J. Comp. Neurol.493, 99–110 (2005).
  • Kim MA, Lee HS, Lee BY, Waterhouse BD. Reciprocal connections between subdivisions of the dorsal raphe and nuclear core of the locus coeruleus. Brain Res.1026, 56–67 (2004).
  • Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. J. Clin. Psychiatry66(Suppl. 8), 30–40 (2005).
  • Blier P, Tremblay P. Physiologic mechanisms underlying the antidepressant discontinuation syndrome. J. Clin. Psychiatry67(Suppl. 4), 8–13 (2006).
  • Tusa RJ. Dizziness. Med. Clin. N. Am.93, 263–271 (2009).
  • Fotuhi M, Glaun B, Quan SY, Sofare T. Vestibular migraine: a critical review of treatment trials. J. Neurol.256, 711–716 (2009).
  • Shank RP, Maryanoff BE. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. CNS Neurosci. Ther.14, 120–142 (2008).
  • Eisenberg E, River Y, Shifrin A, Krivoy N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs67, 1265–1289 (2007).
  • Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell. Mol. Life Sci.64, 2090–2103 (2007).
  • Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope108(Suppl. 85), 1–28 (1998).
  • Simon NM, Parker SW, Wernick-Robinson M et al. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics46, 334–339 (2005).
  • Staab JP, Ruckenstein MJ, Amsterdam JD. A prospective trial of sertraline for chronic subjective dizziness. Laryngoscope114(9), 1637–1641 (2004).
  • Staab JP, Ruckenstein MJ, Solomon D, Shepard NT. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch. Otolaryngol. Head Neck Surg.128(5), 554–560 (2002).
  • Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br. J. Pharmacol.151, 737–748 (2007).
  • Sanchez C, Hyttel J. Comparison of effects of antidepressants and their metabolites on reuptake of biogenic amine and on receptor binding. Cell. Mol. Neurobiol.19, 467–489 (1999).
  • Horii A, Mitani K, Kitahara T et al. Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness. Otol. Neurotol.25, 536–543 (2004).
  • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am. J. Otol.18, 350–354 (1997).
  • Stamford JA, Davidson C, McLaughlin DP, Hopwood SE. Control of dorsal raphe 5-HT function by multiple 5-HT1 autoreceptors: parallel purposes or plurality? Trends Neurosci.23, 459–465 (2000).
  • Cameron OG, Huang GC, Nichols T et al. Reduced γ-aminobutyric acidA-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Arch. Gen. Psychiatry64, 793–800 (2008).
  • Eser D, Leicht G, Lutz J et al. Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. Hum. Brain Mapp.30, 511–522 (2009).
  • Neumeister A, Bain E, Nugent AC et al. Reduced serotonin 1A receptor binding in panic disorder. J. Neurosci.24, 589–591 (2004).
  • Hasler G, Nugent AC, Carlson PJ et al. Altered cerebral γ-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch. Gen. Psychiatry65, 1166–1175 (2008).
  • Szabo ST, Blier P. Serotonin1A receptor ligands act on the norepinephrine neuron firing through excitatory amino acid and GABAA receptors: a microiontophoretic study in the rat locus coeruleus. Synapse42, 203–212 (2001).
  • Liu R, Jolas T, Aghajanian GK. Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res.873, 34–45 (2000).
  • Jacobs BL, Fornal CA. 5-HT and motor control: a hypothesis. Trends Neurosci.16, 346–352 (1993).
  • Cohen B, Raphan T. The physiology of the vestibuloocular reflex (VOR). In: Springer Handbook of Auditory Research: The Vestibular System. Highstein SN, Fay RR, Popper AN (Eds). Springer-Verlag, NY, USA, 235–285 (2004).
  • Cuccarazzu B, Halberstadt AL. Projections from the vestibular nuclei and nucleus prepositus hypoglossi to dorsal raphe nucleus in rats. Neuro. Lett.439, 70–74 (2008).
  • Balaban CD, Schuerger RJ, Porter JD. Zonal organization of flocculo-vestibular connections in rats. Neuroscience99, 669–682 (2000).
  • Ito M. The Cerebellum and Neural Contro 1st Edition. Raven Press, NY, USA (1984).
  • Marano E, Marcelli V, Di Stasio E et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache45(4), 325–331 (2005).
  • Moja L, Cussi C, Sterzi R, Canepari C. Selective serotonin reuptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst. Rev.3, CD002919 (2005).
  • Jackson JL, Shimeall W, Sessums L et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ DOI: 10.1136/bmj.c522 (2010) (Epub ahead of print).
  • Balaban CD. Distribution of putative ‘nociceptive’ ganglion cell markers in the vestibular and spiral ganglia of rats and macaques. Soc. Neurosci. Abstracts, Abstract 583.4 (2010).
  • Kitahara T, Li HS, Balaban CD. Changes in transient receptor potential cation channel superfamily V (TRPV) mRNA expression in the mouse inner ear ganglia after kanamycin challenge. Hear. Res.201(1–2), 132–144 (2005).
  • Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain126, 1801–1813 (2003).
  • Wilson VJ, Melvill Jones G. Mammalian Vestibular Physiology . Plenum, NY, USA (1974).
  • Koo JW, Balaban CD. Serotonin-induced plasma extravasation in the murine inner ear: possible mechanism of migraine-associated inner ear dysfunction. Cephalagia26, 1310–1319 (2006).
  • Oh CK, Drescher MJ, Hatfield JS, Drescher DG. Selective expression of serotonin receptor transcripts in the mammalian cochlea and its subdivisions. Hear. Res.70, 135–140 (1999).
  • Vass Z, Dai CF, Steyger PS et al. Co-localization of the vanilloid capsaicin receptor and substance P in sensory nerve fibers innervating cochlear and vertebro-basilar arteries. Neuroscience124, 919–927 (2004).
  • Vass Z, Shore SE, Nuttall AL, Miller JM. Direct evidence of trigeminal innervation of cochlear blood vessels. Neuroscience84, 559–567 (1998).
  • Napier C, Stewart M, Melrose H et al. Characterization of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur. J. Pharmacol.368, 259–268 (1999).
  • Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs60, 1259–1287 (2000).
  • Wood MD, Thomas DR, Watson JM. Therapeutic potential of serotonin antagonists in depressive disorders. Expert Opin. Investig. Drugs11, 457–467 (2002).
  • Goadsby PJ, Lipton RB, Ferrari MD. Drug therapy: migraine – current understanding and treatment. N. Engl. J. Med.346, 257–270 (2002).
  • Silva SA, Marques FB, Fontes Ribero CA. Characterization of the human basilar artery contractile response to 5-HT and triptans. Fundam. Clin. Pharmacol.21, 265–272 (2006).
  • Gopen Q, Rosowski JJ, Merchant SN. Anatomy of the normal human cochlear aqueduct with functional implications. Hear. Res.107, 9–22 (1997).
  • Janjua R, Al-Mefty O, Densler DW, Shields CB. Dural relationships of Meckel cave and lateral wall of the cavernous sinus. Neurosurg. Focus25(6), E2 (2008).
  • Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat. Clin. Pract. Neurol.3, 256–263 (2007).
  • Sehba FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol. Res.28, 381–398 (2006).
  • Schuknecht HF. Pathology of the Ear. Harvard University Press, MA, USA, 503 (1974).
  • Cambj-Sapunar L, Yu M, Harder DR, Roman RJ. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34, 1264–1275 (2003).
  • Donaldson C, Boers PM, Hoskin KL, Zagami AS, Lambert GA. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons. Neurophamacology42, 374–385 (2002).
  • Goadsby PJ, Classey JD. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience122, 491–498 (2003).
  • Jeggo RD, Wang Y, Jordan D, Ramage AG. Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre input. Br. J. Pharmacol.150, 987–995 (2007).
  • Balaban CD. Vestibular autonomic regulation. Curr. Opin. Neurol.12, 29–33 (1999).
  • Olesen J, Diener HC, Husstedt IW et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med.350, 1104–1110 (2004).
  • Ho TW, Mannix LK, Fan X et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology70, 1304–1312 (2008).
  • Connor KM, Shapiro RE, Diener HC et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology73, 970–977 (2009).
  • Villalòn CM, Olesen J. The role of CGRP in the pathophysiology of migraine and the efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol. Ther.124, 309–324 (2009).
  • Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, GA, USA, 45 (2003).
  • Hoffer ME, Balaban CD, Gottschall KR et al. Blast exposure: vestibular consequences and associated characteristics. Otol. Neurotol.31, 232–236 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.